Geurts van Kessel A H, den Boer W C, van Agthoven A J, Hagemeijer A
Somatic Cell Genet. 1981 Nov;7(6):645-56. doi: 10.1007/BF01538754.
Interspecific hybrid cells, derived from fusion of normal and leukemic (CML) human leukocytes with tumorigenic P19 mouse or a3 Chinese hamster cells, were tested for their tumor-forming capacity in congenitally athymic nude mice. Partial suppression of tumorigenicity was observed in several hybrid clones derived from both normal and leukemic leukocytes. Chromosome analysis of the hybrid cells before inoculation in nude mice and of the derived tumors did not reveal a human chromosome bearing factor(s) which singly appeared responsible for suppression. The presence of the Philadelphia translocation in the leukemic cells does not seem to have deprived these cells of their tumor-suppressing ability.
通过将正常和白血病(慢性粒细胞白血病)人白细胞与致瘤性P19小鼠或a3中国仓鼠细胞融合得到的种间杂交细胞,在先天性无胸腺裸鼠中测试其形成肿瘤的能力。在源自正常和白血病白细胞的几个杂交克隆中观察到致瘤性的部分抑制。在将杂交细胞接种到裸鼠之前以及对衍生肿瘤进行的染色体分析未发现单独负责抑制的携带人类染色体的因子。白血病细胞中费城易位的存在似乎并未剥夺这些细胞的肿瘤抑制能力。